Clinical Approach to Behavior or Personality Change
Pediatric Neurology Framework1. Symptom Overview
Understanding the clinical significance and classification of behavior or personality change in children
Behavior or personality change in children represents one of the most diagnostically challenging presentations in pediatric neurology. While behavioral symptoms are common in childhood — with approximately 15-20% of children experiencing some form of behavioral or emotional disorder — acute or subacute changes from baseline personality warrant careful neurological evaluation. Studies indicate that up to 5% of children presenting to pediatric emergency departments with acute behavioral changes have an underlying organic cause, including potentially life-threatening conditions such as encephalitis, intracranial tumors, or autoimmune encephalopathy.
The challenge lies in distinguishing primary psychiatric disorders from neurological conditions manifesting with behavioral symptoms. Approximately 2-3 per 100,000 children annually are diagnosed with autoimmune encephalitis, a condition that frequently presents with psychiatric symptoms before neurological signs become apparent. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, the most common autoimmune encephalitis in children, presents with behavioral or personality changes as the initial symptom in over 80% of pediatric cases.
Definition
Behavior or personality change refers to a noticeable alteration in a child’s typical patterns of thinking, feeling, or acting that represents a departure from their established baseline. This includes changes in mood, affect, social interaction, impulse control, cognition, or fundamental personality traits. In the neurological context, these changes may reflect underlying dysfunction of brain structures involved in emotion regulation, executive function, social cognition, or consciousness.
Key Epidemiology
- Behavioral disorders affect 15-20% of children and adolescents globally
- Acute behavioral changes have an organic cause in approximately 5% of emergency presentations
- Autoimmune encephalitis incidence: 2-3 per 100,000 children annually
- Anti-NMDA receptor encephalitis: Most common autoimmune encephalitis in children, median age 14 years
- Brain tumors present with behavioral changes as initial symptom in 10-20% of pediatric cases
- Pediatric Acute-onset Neuropsychiatric Syndrome (PANS): Estimated prevalence of 1 in 200 children
Classification by Duration
The temporal profile of behavioral change is crucial for differential diagnosis. Acute onset suggests infectious, toxic, metabolic, or vascular etiologies, while insidious changes may indicate neurodegenerative conditions, slow-growing tumors, or evolving psychiatric disorders.
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Hours to days (less than 1 week) | Encephalitis, intoxication, metabolic derangement, seizures, traumatic brain injury, stroke | High likelihood of organic cause; requires urgent evaluation to exclude life-threatening conditions |
| Subacute | 1 to 4 weeks | Autoimmune encephalitis, PANS/PANDAS, evolving infection, medication effects, early tumor presentation | Intermediate urgency; autoimmune and inflammatory causes more likely; may have fluctuating course |
| Chronic/Insidious | Greater than 4 weeks | Brain tumors, neurodegenerative disorders, metabolic diseases, chronic psychiatric conditions, substance abuse | Broader differential; neuroimaging essential; may represent primary psychiatric disorder but organic causes must be excluded |
Classification by Type of Change
Behavioral and personality changes can manifest in various domains, and the pattern of change often provides diagnostic clues about the underlying neuroanatomical substrate.
Externalizing Changes
Characteristics: Increased aggression, irritability, impulsivity, hyperactivity, disinhibition, oppositional behavior, tantrums, property destruction
Neuroanatomical correlates: Frontal lobe dysfunction (orbitofrontal, ventromedial prefrontal cortex), limbic system involvement, basal ganglia pathology
Suggests: Frontal lobe lesions, autoimmune encephalitis, traumatic brain injury, substance intoxication
Internalizing Changes
Characteristics: Withdrawal, depression, anxiety, fearfulness, apathy, anhedonia, reduced social engagement, emotional blunting
Neuroanatomical correlates: Limbic system, medial prefrontal cortex, anterior cingulate, hypothalamic-pituitary axis
Suggests: Limbic encephalitis, hypothalamic tumors, metabolic disorders, medication effects
Cognitive-Behavioral Changes
Characteristics: Confusion, disorientation, memory problems, attention deficits, academic decline, speech and language regression, executive dysfunction
Neuroanatomical correlates: Diffuse cortical involvement, temporal lobes, dorsolateral prefrontal cortex, hippocampus
Suggests: Encephalitis, metabolic encephalopathy, hydrocephalus, demyelinating disease, neurodegenerative conditions
Psychotic-Like Changes
Characteristics: Hallucinations (visual more concerning than auditory), delusions, paranoia, bizarre behavior, disorganized thinking, catatonia
Neuroanatomical correlates: Limbic system, temporal lobes, thalamus, widespread cortical dysfunction
Suggests: Anti-NMDA receptor encephalitis, other autoimmune encephalitides, drug intoxication, metabolic disorders, early-onset schizophrenia (requires exclusion of organic causes)
Classification by Pattern and Associated Features
| Pattern | Description | Suggests |
|---|---|---|
| Fluctuating course | Waxing and waning symptoms, varying severity throughout the day or week | Autoimmune encephalitis, metabolic disorders, seizure-related changes, delirium |
| Progressive deterioration | Steady worsening over time without improvement | Brain tumor, neurodegenerative disease, chronic infection, untreated hydrocephalus |
| Episodic/Paroxysmal | Discrete episodes of altered behavior with return to baseline | Seizures (especially temporal lobe epilepsy), migraine variants, metabolic crises, paroxysmal movement disorders |
| Post-infectious onset | Behavioral changes following febrile illness or documented infection | PANS/PANDAS, post-infectious autoimmune encephalitis, post-viral encephalopathy |
| Associated movement abnormalities | Behavioral changes accompanied by tics, chorea, dystonia, or stereotypies | Autoimmune encephalitis, basal ganglia disorders, Sydenham chorea, Wilson disease, neurometabolic disorders |
| Sleep disturbance predominant | Severe insomnia, sleep-wake cycle disruption, hypersomnia | Anti-NMDA receptor encephalitis, hypothalamic lesions, limbic encephalitis, Kleine-Levin syndrome |
| Regression of skills | Loss of previously acquired developmental milestones, language, or motor skills | Neurodegenerative disease, metabolic disorders, Landau-Kleffner syndrome, Rett syndrome, disintegrative disorder |
Age-Specific Considerations
The presentation and differential diagnosis of behavioral changes varies significantly across pediatric age groups, reflecting both the evolving vulnerability of the developing brain and age-specific disease predilections.
| Age Group | Typical Presentations | Key Differential Considerations | Assessment Challenges |
|---|---|---|---|
| Infants (0-1 year) | Irritability, poor feeding, altered sleep, reduced social engagement, developmental stagnation or regression | Metabolic disorders, congenital infections, non-accidental trauma, inborn errors of metabolism, early infantile epileptic encephalopathy | Limited behavioral repertoire; relies heavily on parental report of change from baseline; difficult to distinguish neurological from medical illness |
| Toddlers (1-3 years) | Tantrums, aggression, sleep disturbance, language regression, social withdrawal, stereotypic behaviors | Autism spectrum disorder presentation/regression, Landau-Kleffner syndrome, lead poisoning, post-infectious encephalopathy, early-onset epilepsy | Normal developmental variability in behavior; limited verbal communication; “terrible twos” may mask pathology |
| Preschool (3-5 years) | Regression, new fears/anxiety, behavioral outbursts, hallucinations (note: imaginary friends normal at this age), sleep problems | PANS/PANDAS, early brain tumors, metabolic disorders, environmental exposures, early ADHD presentation | Rich fantasy life makes psychiatric symptoms harder to interpret; behavioral vocabulary limited; high baseline activity level |
| School-age (6-12 years) | Academic decline, personality change, new obsessive-compulsive behaviors, movement abnormalities, mood changes | PANS/PANDAS, autoimmune encephalitis, brain tumors, absence epilepsy, learning disabilities unmasked by academic demands | Better able to describe symptoms; academic performance provides objective marker; social comparison with peers helpful |
| Adolescents (12-18 years) | Psychotic symptoms, mood instability, personality change, risk-taking behavior, cognitive decline, movement disorders | Anti-NMDA receptor encephalitis, substance abuse, primary psychiatric disorders (onset age), brain tumors, neurodegenerative diseases | Normal adolescent turmoil may mask pathology; privacy concerns may limit history; substance use must always be considered; pubertal timing affects presentation |
Key Concept: “Red Flags for Organic Cause”
The following features should raise suspicion for an underlying neurological rather than primary psychiatric etiology:
- Acute or subacute onset of symptoms (hours to weeks rather than months)
- Atypical age of onset for the suspected psychiatric diagnosis
- Presence of neurological signs (seizures, movement disorders, focal deficits, altered consciousness)
- Visual hallucinations (more suggestive of organic cause than auditory hallucinations)
- Fluctuating level of consciousness or orientation
- Developmental regression or loss of previously acquired skills
- Poor or paradoxical response to standard psychiatric medications
- Autonomic instability (temperature dysregulation, blood pressure changes, tachycardia)
- Associated systemic symptoms (fever, weight loss, headache)
Impact on Child and Family
Behavioral and personality changes in children have profound effects extending beyond the individual child. Academic performance often deteriorates, with studies showing that children with significant behavioral disturbances miss an average of 20 additional school days per year. Family stress is substantial, with parental rates of anxiety and depression significantly elevated. Siblings may experience behavioral problems of their own in response to family disruption. Early recognition and appropriate management of the underlying cause can prevent long-term neurodevelopmental consequences and improve outcomes for the entire family unit.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of behavior or personality change in children
Behavior and personality emerge from the integrated function of distributed neural networks involving cortical and subcortical structures. The developing pediatric brain is particularly vulnerable to disruption due to ongoing myelination, synaptic pruning, and neuroplasticity. Understanding the neuroanatomical and neurochemical substrates of behavior helps clinicians localize pathology and guides diagnostic investigation. Unlike adult presentations, pediatric behavioral changes must be interpreted in the context of normal developmental trajectories and age-appropriate brain maturation.
Neural Networks of Behavior and Emotion
Behavior and personality are mediated by several interconnected brain networks. Disruption of any component can produce behavioral changes, and the specific pattern of dysfunction often reflects the anatomical localization of the underlying pathology.
| Network/Structure | Key Components | Function | Dysfunction Manifestations |
|---|---|---|---|
| Prefrontal Cortex | Dorsolateral prefrontal cortex, orbitofrontal cortex, ventromedial prefrontal cortex, anterior cingulate cortex | Executive function, decision-making, impulse control, social cognition, working memory, emotional regulation | Disinhibition, impulsivity, poor judgment, apathy, personality change, perseveration, social inappropriateness |
| Limbic System | Amygdala, hippocampus, hypothalamus, cingulate gyrus, fornix, mammillary bodies | Emotion processing, fear response, memory consolidation, autonomic regulation, motivation | Emotional lability, anxiety, aggression, memory impairment, autonomic dysregulation, altered appetite and sleep |
| Basal Ganglia | Caudate, putamen, globus pallidus, nucleus accumbens, subthalamic nucleus | Motor control, habit formation, reward processing, procedural learning, mood regulation | Movement disorders (chorea, tics, dystonia), obsessive-compulsive symptoms, apathy, impulse control disorders |
| Thalamus | Multiple nuclei serving as relay stations for sensory, motor, and limbic information | Sensory gating, arousal regulation, cortical-subcortical integration | Altered consciousness, attention deficits, sensory misperceptions, sleep-wake disturbance |
| Default Mode Network | Medial prefrontal cortex, posterior cingulate, angular gyrus, temporal poles | Self-referential thinking, social cognition, autobiographical memory, mind-wandering | Altered sense of self, depersonalization, social cognition deficits, impaired theory of mind |
| Brainstem | Reticular activating system, locus coeruleus, raphe nuclei, ventral tegmental area | Arousal, sleep-wake regulation, attention, monoamine neurotransmitter production | Altered consciousness, sleep disturbance, autonomic instability, attention dysregulation |
Neurotransmitter Systems and Clinical Relevance
Multiple neurotransmitter systems modulate behavior and are targets for both pathological processes and therapeutic interventions.
Dopaminergic System
Pathways: Mesolimbic (reward), mesocortical (cognition), nigrostriatal (motor)
Functions: Motivation, reward, motor control, executive function
Dysfunction: Psychosis (excess), apathy and anhedonia (deficit), movement disorders
Clinical relevance: Anti-NMDA receptor encephalitis affects dopamine signaling; basal ganglia autoimmune conditions; medication effects
Glutamatergic System
Receptors: NMDA, AMPA, kainate, metabotropic glutamate receptors
Functions: Excitatory neurotransmission, synaptic plasticity, learning, memory
Dysfunction: Excitotoxicity, seizures, cognitive impairment, psychosis
Clinical relevance: Anti-NMDA receptor encephalitis directly targets glutamate receptors; critical in autoimmune encephalopathies
GABAergic System
Receptors: GABA-A (ionotropic), GABA-B (metabotropic)
Functions: Inhibitory neurotransmission, anxiety modulation, seizure threshold
Dysfunction: Seizures, anxiety, agitation, movement disorders
Clinical relevance: Anti-GABA receptor encephalitis; drug effects; metabolic disorders affecting GABA synthesis
Serotonergic System
Origin: Raphe nuclei with widespread projections
Functions: Mood regulation, anxiety, sleep, appetite, impulse control
Dysfunction: Depression, anxiety, obsessive-compulsive symptoms, aggression
Clinical relevance: Target of SSRIs; affected in limbic encephalitis; serotonin syndrome consideration
Noradrenergic System
Origin: Locus coeruleus
Functions: Arousal, attention, stress response, fight-or-flight
Dysfunction: Attention deficits, hyperarousal, autonomic dysregulation
Clinical relevance: Affected in traumatic brain injury; target of ADHD medications; pheochromocytoma effects
Cholinergic System
Origin: Basal forebrain, brainstem nuclei
Functions: Memory, attention, arousal, autonomic function
Dysfunction: Cognitive impairment, delirium, autonomic symptoms
Clinical relevance: Anticholinergic toxicity; autoantibodies to acetylcholine receptors; myasthenia-associated encephalopathy
Mechanisms by Disease Category
| Condition Category | Pathophysiological Mechanism | Brain Regions Affected | Behavioral Manifestations |
|---|---|---|---|
| Autoimmune Encephalitis (Anti-NMDA receptor) | Antibodies against GluN1 subunit of NMDA receptor cause receptor internalization, reducing glutamatergic transmission; disrupts synaptic plasticity and excitatory-inhibitory balance | Limbic system (hippocampus, amygdala), frontal cortex, basal ganglia; predominantly affects areas with high NMDA receptor density | Psychiatric symptoms (80-90% as initial presentation), personality change, psychosis, catatonia, movement disorders, autonomic instability, seizures |
| PANS/PANDAS | Post-infectious autoimmune response; molecular mimicry between streptococcal antigens and basal ganglia neurons; neuroinflammation and blood-brain barrier disruption | Basal ganglia (caudate, putamen), thalamus; frontal-subcortical circuits | Acute-onset obsessive-compulsive disorder, tics, anxiety, emotional lability, cognitive changes, behavioral regression, sleep disturbance |
| Infectious Encephalitis | Direct viral invasion of neurons, inflammatory response, cytokine-mediated damage, cerebral edema; herpes simplex virus has predilection for temporal lobes | Herpes simplex virus: temporal and frontal lobes, limbic system; varies by pathogen | Personality change, behavioral disinhibition, memory impairment, hallucinations, confusion, aggression, altered consciousness |
| Brain Tumors | Mass effect, infiltration, disruption of neural networks, peritumoral edema, hydrocephalus, endocrine effects (hypothalamic-pituitary tumors) | Depends on location; frontal tumors commonly present with behavioral changes; hypothalamic tumors affect mood and appetite | Personality change, disinhibition (frontal), memory problems (temporal), visual symptoms (occipital), endocrine-behavioral (hypothalamic) |
| Metabolic Encephalopathy | Disruption of cellular energy metabolism, accumulation of toxic metabolites, neurotransmitter synthesis abnormalities, mitochondrial dysfunction | Often diffuse; basal ganglia vulnerable in mitochondrial disease; white matter in leukodystrophies | Acute: confusion, lethargy, irritability; Chronic: developmental regression, personality change, cognitive decline |
| Seizure-Related Changes | Ictal behavioral changes (temporal lobe seizures); postictal confusion and behavioral alteration; interictal psychiatric symptoms; effects of antiepileptic drugs | Temporal lobe epilepsy particularly associated with behavioral changes; frontal lobe seizures can present bizarrely | Ictal: automatisms, fear, déjà vu, altered awareness; Interictal: depression, anxiety, psychosis; Postictal: confusion, aggression |
| Toxic/Drug-Induced | Direct neurotoxicity, receptor agonism/antagonism, mitochondrial toxicity, oxidative stress, neurotransmitter depletion or excess | Varies by agent; heavy metals affect basal ganglia; carbon monoxide affects globus pallidus; diffuse cortical effects with many substances | Acute intoxication: confusion, agitation, hallucinations; Chronic exposure: personality change, cognitive decline, movement disorders |
| Neurodegenerative Diseases | Progressive neuronal loss, protein aggregation, mitochondrial dysfunction; disease-specific patterns of degeneration | Wilson disease: basal ganglia, cerebral cortex; Huntington disease: striatum; Adrenoleukodystrophy: posterior white matter then frontal | Progressive personality change, cognitive decline, psychiatric symptoms often preceding motor symptoms, behavioral regression |
Often Overlooked Mechanism: The Limbic-Frontal Connection
Many conditions that present with “psychiatric” symptoms actually reflect dysfunction of the limbic-frontal network rather than primary psychiatric disease. The limbic system (particularly the amygdala and hippocampus) has extensive reciprocal connections with the prefrontal cortex. Autoimmune conditions, such as anti-NMDA receptor encephalitis, frequently target limbic structures with high receptor density. This explains why psychiatric symptoms — including psychosis, anxiety, personality change, and mood disturbance — are often the first manifestation, appearing days to weeks before more obviously “neurological” signs such as seizures or movement disorders. In children presenting with new-onset psychiatric symptoms, particularly with atypical features or rapid onset, always consider that the limbic-frontal network may be under attack from an autoimmune or inflammatory process.
Developmental Considerations in Pathophysiology
The pediatric brain differs fundamentally from the adult brain in ways that affect both vulnerability to insult and clinical presentation of pathology.
| Developmental Factor | Description | Clinical Implications |
|---|---|---|
| Ongoing Myelination | Myelination continues from infancy through early adulthood, with frontal lobes myelinating last (into mid-20s) | Demyelinating conditions may present differently than in adults; white matter more vulnerable; frontal functions (executive control, impulse regulation) mature last |
| Synaptic Pruning | Elimination of excess synapses occurs throughout childhood and adolescence, particularly in prefrontal cortex during teenage years | Abnormal pruning may contribute to psychiatric disorders; brain injury during critical periods may have different effects than in mature brain |
| Neuroplasticity | Pediatric brain has greater capacity for reorganization and recovery but also greater vulnerability to aberrant plasticity | Better recovery potential from some injuries; however, early insults can alter developmental trajectory; critical periods exist for various functions |
| Blood-Brain Barrier Maturation | Blood-brain barrier is functional but continues to mature; may be more permeable in young children | May allow greater entry of toxins, medications, and autoantibodies; explains some age-specific vulnerabilities |
| Neurotransmitter System Development | Neurotransmitter systems mature at different rates; dopaminergic system particularly active during adolescence | Explains age-specific responses to medications; adolescent vulnerability to substance effects; timing of psychiatric disorder onset |
| Immune System-Brain Interactions | Developing immune system and brain have complex bidirectional interactions; microglia play crucial developmental roles | Maternal immune activation can affect fetal brain development; post-infectious autoimmune syndromes more common in children; neuroinflammation affects neurodevelopment |
Frontal Lobe Development and Behavioral Implications
The protracted development of the frontal lobes has particular relevance for understanding behavioral changes in children. The prefrontal cortex is the last brain region to fully mature, with development continuing into the mid-twenties. This has several important implications:
Baseline Considerations
- Normal children have limited impulse control compared to adults
- Executive function develops gradually throughout childhood
- Emotional regulation improves with age as prefrontal-limbic connections strengthen
- Apparent “frontal” symptoms in young children may reflect normal immaturity rather than pathology
Pathological Implications
- Frontal lobe lesions in children may be “silent” initially, becoming apparent only as peers mature
- Early frontal injury may prevent normal development of executive skills
- Behavioral changes may be attributed to “phase” or “attitude” rather than pathology
- Comparison with developmental norms essential for accurate assessment
Complications of Behavioral Changes Themselves
Beyond reflecting underlying pathology, severe behavioral changes can lead to secondary complications that compound the clinical picture:
| Complication | Mechanism | Prevention/Management |
|---|---|---|
| Self-injury | Impulsivity, psychosis, severe agitation, or response to hallucinations | Close supervision, safe environment, appropriate sedation if needed, treat underlying cause urgently |
| Nutritional compromise | Food refusal, feeding difficulties, altered appetite regulation | Nutritional support, consider nasogastric feeding if severe, monitor weight and hydration |
| Sleep deprivation | Insomnia from limbic dysfunction, may worsen behavioral symptoms | Sleep hygiene, melatonin, short-term sedation; treat underlying cause |
| Academic decline | Cognitive impairment, school absence, attention deficits | Educational support, school communication, neuropsychological assessment |
| Social isolation | Peer rejection, withdrawal, family stress | Social work support, family education, peer education when appropriate |
| Medication side effects | Sedation, metabolic effects, movement disorders from antipsychotics | Judicious medication use, regular monitoring, minimize polypharmacy, treat underlying cause to reduce medication need |
Integration of Pathophysiology into Clinical Reasoning:
Understanding pathophysiology guides the clinical approach in several ways:
- Pattern recognition: Limbic symptoms (memory, emotion, behavior) with movement disorders suggests autoimmune encephalitis affecting both limbic and basal ganglia circuits
- Investigation targeting: Frontal behavioral changes with hydrocephalus features should prompt neuroimaging; post-infectious onset should prompt autoimmune workup
- Therapeutic implications: Conditions affecting neurotransmitter systems may respond differently to psychiatric medications; autoimmune conditions require immunotherapy
- Prognostic insight: Understanding mechanism helps predict recovery potential and guides rehabilitation
3. History Taking
A comprehensive approach to eliciting the history of behavior or personality change in children
Red Flags — Require Urgent Evaluation
- Acute onset (hours to days) — Suggests encephalitis, intoxication, metabolic crisis, or vascular event
- Altered level of consciousness — Indicates organic encephalopathy; requires immediate workup
- New-onset seizures — May indicate autoimmune encephalitis, infection, or structural lesion
- Fever with behavioral change — Suggests infectious encephalitis until proven otherwise
- Visual hallucinations — More suggestive of organic cause than auditory hallucinations
- Autonomic instability — Tachycardia, blood pressure fluctuations, hyperthermia suggest autoimmune encephalitis or intoxication
- Movement disorders — Chorea, dystonia, orofacial dyskinesias with behavioral change suggest autoimmune or basal ganglia pathology
- Developmental regression — Loss of previously acquired skills suggests neurodegenerative disease or encephalitis
- Severe headache with personality change — Suggests raised intracranial pressure, mass lesion, or meningitis
- Rapid cognitive decline — May indicate progressive encephalopathy requiring urgent investigation
- Catatonia — Immobility, mutism, posturing — highly associated with autoimmune encephalitis in children
- Recent head trauma — Even mild trauma can cause behavioral changes; consider subdural hematoma in younger children
History taking in pediatric behavioral change requires a dual approach: obtaining detailed information from caregivers while also engaging directly with the child at an age-appropriate level. The history should systematically address the nature, onset, and progression of symptoms while screening for red flags that suggest organic etiology. Remember that children with behavioral changes may be unreliable historians, and collateral history from multiple sources (parents, teachers, other caregivers) is essential.
Systematic History: The “BEHAVIOR” Approach
Use the mnemonic “BEHAVIOR” to ensure comprehensive history taking for personality and behavioral changes:
- B — Baseline and Birth: What was the child’s normal baseline? Birth history, developmental trajectory, and premorbid personality
- E — Evolution of Change: When did it start? How has it progressed? Sudden versus gradual onset? Fluctuating or progressive?
- H — Hallmarks and Specific Symptoms: What specific changes are present? Mood, cognition, psychosis, movement, sleep, appetite?
- A — Antecedents and Triggers: Any preceding illness, infection, trauma, stressor, medication change, or toxic exposure?
- V — Vital Associated Features: Seizures, headaches, fever, neurological symptoms, autonomic changes, movement disorders?
- I — Impact and Function: How is this affecting school, social life, family? Sleep patterns? Self-care abilities?
- O — Other History: Past medical history, family psychiatric and neurological history, medications, immunizations
- R — Risk Assessment: Any safety concerns? Self-harm? Harm to others? Wandering? Supervision needs?
Detailed History Components
Baseline and Developmental History
Establishing the child’s premorbid baseline is essential for recognizing the nature and extent of change.
| Component | Key Questions | Clinical Significance |
|---|---|---|
| Birth History | Gestational age? Birth weight? Complications during pregnancy or delivery? NICU admission? Need for resuscitation or oxygen? | Perinatal complications increase risk for neurodevelopmental disorders and may predispose to later neurological vulnerability |
| Developmental Milestones | When did they walk? First words? Sentences? Toilet training? Any concerns about development before this change? | Prior developmental delays may indicate underlying neurological condition; regression from normal milestones is a red flag |
| Premorbid Personality | What was the child like before? Temperament? Social? Shy? Active? How would you describe their personality? | Establishes baseline against which to measure change; premorbid traits influence presentation |
| Academic Performance | How were they doing in school before? Any learning difficulties? Recent grade changes? Teacher concerns? | Academic decline may precede obvious behavioral changes; provides objective marker of cognitive function |
| Social Functioning | How were friendships? Extracurricular activities? Family relationships? | Social withdrawal may be early sign; establishes baseline social competence |
Characterizing the Behavioral Change
| Aspect | Key Questions | Diagnostic Implications |
|---|---|---|
| Onset | “When exactly did you first notice something was different?” “Can you pinpoint a day or week?” “Was there a specific event?” | Acute (hours-days): infection, intoxication, vascular. Subacute (weeks): autoimmune, tumor. Insidious (months): neurodegenerative, slow-growing tumor, psychiatric |
| Progression | “Is it getting worse, better, or staying the same?” “Does it come and go?” “Are there good days and bad days?” | Progressive: tumor, neurodegeneration. Fluctuating: autoimmune encephalitis, seizure-related, metabolic. Episodic: seizures, migraine variants |
| Specific Changes | “What specifically is different?” Probe for: aggression, withdrawal, mood changes, sleep, appetite, fears, obsessions, hallucinations, confusion | Pattern of symptoms suggests affected brain networks (see pathophysiology); helps differentiate psychiatric from neurological |
| Timing Patterns | “Is it worse at certain times of day?” “After meals?” “With fatigue?” “Relationship to sleep?” | Morning worsening: raised intracranial pressure. Postprandial: metabolic. Evening: fatigue-related. Episodic at any time: seizures |
| Level of Awareness | “Does the child seem aware of their surroundings during episodes?” “Do they remember afterward?” “Can you get their attention?” | Altered awareness suggests organic cause (encephalopathy, seizures); preserved awareness more consistent with psychiatric etiology |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features to Elicit | Specific Questions to Ask |
|---|---|---|
| Autoimmune Encephalitis (including Anti-NMDA receptor encephalitis) | Subacute onset, psychiatric symptoms, seizures, movement disorders, autonomic instability, sleep disturbance | “Has there been any abnormal movements of the face or body?” “Any seizure-like episodes?” “Problems with sleep — staying awake all night?” “Any fever or illness before this started?” “Has their speech become slurred or strange?” |
| PANS/PANDAS | Acute dramatic onset, obsessive-compulsive symptoms, tics, anxiety, preceding infection (especially streptococcal) | “Did this come on very suddenly — like overnight?” “Any new rituals, repetitive behaviors, or fears?” “Has there been a sore throat, scarlet fever, or strep infection recently?” “Any new tics or movements?” “Problems with urination or new bedwetting?” |
| Infectious Encephalitis | Fever, headache, altered consciousness, seizures, focal neurological signs, recent viral illness | “Any fever?” “Headache or neck stiffness?” “Any recent illness — cold sores, flu-like symptoms?” “Has there been any confusion or not recognizing family members?” “Any travel history or animal exposures?” |
| Brain Tumor | Progressive symptoms, morning headaches, vomiting, visual changes, focal signs, gait disturbance | “Any headaches — especially in the morning or that wake them from sleep?” “Any vomiting without nausea?” “Vision problems?” “Difficulty with walking or coordination?” “Growth or puberty changes?” |
| Seizure-Related Changes | Episodic symptoms, staring spells, post-event confusion, nocturnal events, automatisms | “Any staring spells or ‘spacing out’?” “Odd repetitive movements during episodes?” “Confusion after episodes?” “Any tongue biting or incontinence?” “Events during sleep — unusual movements or sounds?” |
| Metabolic Disorder | Episodic decompensation, relationship to fasting or illness, developmental regression, organomegaly | “Does it get worse when they’re sick or haven’t eaten?” “Any unusual body odor?” “Problems in other family members?” “Enlarged liver or spleen noticed?” “Dietary protein intolerance?” |
| Toxic Exposure/Intoxication | Acute onset, access to substances, environmental exposures, medication changes | “Any new medications or recent medication changes?” “Could they have gotten into any medications or substances?” “Any recreational drug use?” “New house, renovations, or lead paint exposure?” “What cleaning products or chemicals are accessible?” |
| Wilson Disease | Adolescent onset, tremor, dysarthria, liver disease, psychiatric symptoms preceding neurological | “Any tremor or shakiness?” “Changes in speech or handwriting?” “Jaundice or liver problems?” “Any brownish ring around the eyes?” “Family history of liver disease or neurological problems?” |
Associated Symptoms to Screen For
Neurological Symptoms
- Headaches: Character, location, timing, associated symptoms
- Seizures: Convulsive and non-convulsive episodes
- Movement disorders: Tremor, chorea, tics, dystonia
- Motor symptoms: Weakness, coordination problems, gait changes
- Sensory symptoms: Numbness, tingling, visual changes
- Speech changes: Slurring, word-finding difficulty, mutism
- Swallowing difficulty: May indicate brainstem involvement
Systemic Symptoms
- Fever: Infectious or inflammatory cause
- Weight changes: Loss (malignancy, metabolic) or gain (hypothalamic)
- Sleep disturbance: Insomnia common in autoimmune encephalitis
- Appetite changes: Hypothalamic involvement
- Autonomic symptoms: Sweating, temperature dysregulation, heart rate changes
- Urinary symptoms: New incontinence or retention
- Pubertal changes: Precocious or delayed puberty (hypothalamic)
Medication and Substance History
Medications That Can Cause Behavioral Changes
- Corticosteroids: Mood lability, psychosis, mania, depression
- Antiepileptic drugs: Levetiracetam (irritability, aggression), topiramate (cognitive slowing, depression), phenobarbital (behavioral disinhibition)
- Stimulants: Irritability, mood changes, psychosis at high doses
- Antihistamines: Paradoxical excitation in young children
- Beta-agonists (asthma medications): Hyperactivity, sleep disturbance
- Antibiotics: Fluoroquinolones and others can cause neuropsychiatric effects
- Isotretinoin: Depression, mood changes
- Montelukast: Neuropsychiatric events including aggression, depression
Substances to Consider in Adolescents
- Cannabis: Acute psychosis, anxiety, chronic motivational changes
- Synthetic cannabinoids: Severe psychosis, agitation
- Alcohol: Intoxication, withdrawal, Wernicke encephalopathy
- Stimulants (amphetamines, cocaine): Psychosis, agitation
- Hallucinogens: Acute psychosis, persisting perception disorder
- Inhalants: Acute confusion, chronic cognitive damage
- Prescription medication misuse: Opioids, benzodiazepines, stimulants
- Over-the-counter medications: Dextromethorphan, antihistamines, caffeine
Family History
| Category | Specific Conditions to Ask About | Relevance |
|---|---|---|
| Psychiatric History | Schizophrenia, bipolar disorder, severe depression, anxiety disorders, obsessive-compulsive disorder, autism spectrum disorder | Strong genetic component to many psychiatric disorders; helps contextualize presentation but should not preclude organic workup |
| Neurological History | Epilepsy, movement disorders, dementia (especially early-onset), multiple sclerosis, migraines | May suggest inherited neurological conditions; some autoimmune conditions have familial clustering |
| Autoimmune Conditions | Thyroid disease, lupus, rheumatoid arthritis, type 1 diabetes, celiac disease | Family history of autoimmunity increases risk for autoimmune encephalitis and PANS |
| Metabolic/Genetic | Liver disease, neurological deterioration, consanguinity, unexplained childhood deaths | Suggests inherited metabolic disorder; Wilson disease, mitochondrial disease, urea cycle disorders |
Immunization and Infection History
Immunization Status
- Up to date with routine immunizations?
- Recent vaccinations? (rare post-vaccination encephalitis)
- Incomplete pertussis series? (increased pertussis encephalopathy risk)
- Measles vaccination status? (subacute sclerosing panencephalitis in unvaccinated)
Recent and Past Infections
- Recent streptococcal infection? (PANDAS, Sydenham chorea)
- Viral illness in preceding weeks? (post-infectious autoimmune)
- Herpes simplex infections? (HSV encephalitis risk)
- Mycoplasma infection? (associated with autoimmune encephalitis)
- Travel-acquired infections?
Social and Environmental History
| Domain | Key Questions | Clinical Relevance |
|---|---|---|
| Home Environment | Recent moves? Renovations? Old housing with lead paint? Water source? Heating method? | Lead poisoning, carbon monoxide exposure, other environmental toxins |
| School | Current grade? Academic performance? Teacher observations? Bullying? School stressors? | Academic decline as marker of change; school-based observations valuable; psychosocial stressors |
| Family Dynamics | Recent family stressors? Parental separation? Bereavement? Conflict? New siblings? | Psychosocial factors may precipitate or exacerbate symptoms; important for holistic management |
| Trauma History | Any history of physical, emotional, or sexual abuse? Witnessed violence? Accidents? | Trauma can cause behavioral changes; also consider non-accidental injury in younger children with behavioral change |
| Screen Time and Sleep | Hours of screen use? Sleep schedule? Gaming or social media concerns? | Sleep deprivation can cause significant behavioral changes; excessive screen time associated with behavioral issues |
Practical Tip: Interview Technique
When interviewing about behavioral changes:
- Interview parents separately from older children/adolescents — each may provide different information; adolescents may not disclose substance use with parents present
- Obtain collateral history from school — teachers see children in different context and may note changes parents miss
- Review photos and videos — parents may have captured abnormal movements or behaviors on their phones
- Ask about “the day before” — helps establish true baseline and identify any precipitants
- Use timeline approach — construct a chronological narrative of symptom evolution
- Ask about what hasn’t changed — preserved functions help with localization and differential
4. Physical Examination
A systematic approach to examining children with behavior or personality change
Systematic Framework: The examination of a child with behavioral change requires both a thorough general medical examination (to identify systemic causes) and a detailed neurological examination (to identify focal signs and assess mental status). Use the “General to Neurological” approach, with particular attention to mental status, movement disorders, and signs of raised intracranial pressure.
The physical examination serves three main purposes: identifying signs of systemic illness that may explain behavioral changes, detecting neurological abnormalities that suggest organic etiology, and assessing the child’s current mental status and functional level. Examination findings must be interpreted in the context of normal developmental expectations for the child’s age.
Vital Signs
Vital signs abnormalities can provide important diagnostic clues and may indicate the urgency of the situation.
| Vital Sign | Age-Appropriate Normal Ranges | Abnormalities to Note | Clinical Significance |
|---|---|---|---|
| Temperature | 36.5-37.5°C (all ages) | Fever (>38°C), Hypothermia (<36°C), Temperature instability | Fever: infection, inflammation, autoimmune; Hypothermia: severe metabolic, hypothalamic dysfunction; Instability: autonomic dysfunction (autoimmune encephalitis) |
| Heart Rate | Neonate: 100-160; Infant: 100-150; Toddler: 90-140; School age: 70-120; Adolescent: 60-100 | Tachycardia, Bradycardia, Irregular rhythm, Lability | Tachycardia: fever, anxiety, pain, autonomic dysfunction, hyperthyroidism, intoxication; Bradycardia: raised intracranial pressure, hypothyroidism, medication effect |
| Blood Pressure | Use age/height-appropriate percentile charts; generally Systolic: 90-110 + (age×2) mmHg | Hypertension, Hypotension, Lability | Hypertension: raised intracranial pressure (with bradycardia = Cushing response), autonomic dysfunction, pain, intoxication; Hypotension: sepsis, adrenal crisis |
| Respiratory Rate | Neonate: 30-60; Infant: 25-40; Toddler: 20-30; School age: 18-25; Adolescent: 12-20 | Tachypnea, Abnormal patterns (Cheyne-Stokes, ataxic) | Tachypnea: metabolic acidosis, anxiety; Abnormal patterns: brainstem dysfunction, raised intracranial pressure |
| Oxygen Saturation | >95% on room air (all ages) | Hypoxia | Hypoxia can cause confusion and behavioral changes; may indicate respiratory or cardiac pathology |
General Inspection
Much information can be gathered before touching the child. Observation should begin from the moment the child enters the room.
Appearance and Behavior
- Level of consciousness: Alert, drowsy, obtunded, responsive to voice/pain only
- General appearance: Well or unwell, distressed, comfortable
- Interaction: Eye contact, engagement with examiner and parents, appropriate wariness
- Activity level: Hyperactive, hypoactive, agitated, catatonic
- Spontaneous movements: Abnormal movements, tremor, tics, stereotypies
- Posture: Normal, abnormal posturing, asymmetry
Physical Features
- Dysmorphic features: May suggest genetic syndrome
- Nutritional status: Wasting, obesity, cachexia
- Skin: Rashes, bruising, neurocutaneous stigmata
- Hygiene: May reflect self-care ability or neglect
- Growth: Plot height, weight, head circumference on growth charts
- Pubertal status: Precocious or delayed puberty (hypothalamic lesions)
Mental Status Examination
The mental status examination is crucial in children with behavioral changes. Components must be adapted to the child’s developmental level.
| Component | How to Assess | Abnormal Findings and Significance |
|---|---|---|
| Level of Consciousness | Glasgow Coma Scale (modified for children); response to voice and stimulation; ability to maintain attention | Any impairment strongly suggests organic cause; fluctuating consciousness typical of encephalopathy or seizures |
| Orientation | Person (own name, parents’ names), place (where are we?), time (age-appropriate: day of week, time of year) | Disorientation suggests organic encephalopathy; may be difficult to assess in younger children |
| Attention and Concentration | Digit span (age-appropriate), serial subtraction, spelling backwards, days of week backwards | Impaired in delirium, encephalopathy; may also be affected in primary psychiatric conditions |
| Memory | Immediate (repeat 3 words), short-term (recall 3 words after 5 minutes), long-term (recent events, family names) | Memory impairment suggests temporal lobe/hippocampal involvement; prominent in limbic encephalitis |
| Language | Spontaneous speech, naming, comprehension, repetition; note fluency, paraphasic errors, neologisms | Aphasia suggests dominant hemisphere lesion; mutism can be psychiatric or organic (catatonia, frontal lesions) |
| Mood and Affect | Ask how they feel; observe emotional expression, range, appropriateness, congruence | Labile affect common in organic conditions; flat affect in depression or frontal lesions; inappropriate affect concerning for psychosis or organic cause |
| Thought Content | Ask about worries, fears, unusual experiences; probe gently for hallucinations, delusions, obsessions | Visual hallucinations more suggestive of organic cause than auditory; bizarre delusions may be psychiatric or organic |
| Thought Process | Observe organization of speech: logical, tangential, circumstantial, loose associations, thought blocking | Disorganized thinking can be psychiatric or organic; severe disorganization with altered consciousness suggests encephalopathy |
| Insight and Judgment | Does the child recognize something is wrong? Can they make age-appropriate safety decisions? | Impaired insight may be psychiatric or organic; safety judgment critical for disposition decisions |
Age-Appropriate Mental Status Assessment
Infants and toddlers: Assess alertness, response to caregivers, developmental skills (reaching, babbling, walking, words), play behavior, and consolability.
Preschoolers: Can assess orientation to person and place, follow simple commands, name objects, engage in play. Drawing (person, shapes) provides information about cognition and motor control.
School-age children: Can perform most components of mental status exam. Use age-appropriate memory tasks (remember 3 animals), attention tasks (spelling simple words backwards), and age-appropriate questions about mood and experiences.
Adolescents: Full adult mental status exam applicable, but maintain developmentally sensitive approach to questions about mood, substance use, and psychotic symptoms.
Head and Neck Examination
| Structure | What to Examine | Abnormal Findings and Significance |
|---|---|---|
| Head | Circumference (plot on chart), shape, fontanelle (if open), signs of trauma | Macrocephaly: hydrocephalus, storage disorders; Microcephaly: congenital infection, genetic; Bulging fontanelle: raised intracranial pressure; Trauma signs: consider non-accidental injury |
| Eyes | Pupil size and reactivity, eye movements, nystagmus, fundoscopy (papilledema), Kayser-Fleischer rings | Papilledema: raised intracranial pressure; Kayser-Fleischer rings: Wilson disease; Abnormal pupils: drug effect, brainstem lesion; Nystagmus: posterior fossa lesion, intoxication |
| Ears | Otoscopy for middle ear disease | Otitis media: source of infection that could spread intracranially; mastoiditis |
| Nose and Sinuses | Discharge, sinus tenderness | Sinusitis: potential source of intracranial spread |
| Mouth and Throat | Pharyngitis, tonsillar enlargement, dental health, oral movements | Streptococcal pharyngitis: PANDAS trigger; Orofacial dyskinesias: autoimmune encephalitis, tardive dyskinesia |
| Neck | Meningism (neck stiffness), lymphadenopathy, thyroid | Meningism: meningitis, encephalitis, subarachnoid hemorrhage; Thyromegaly: hyper/hypothyroidism causing behavioral symptoms |
Neurological Examination
Cranial Nerves
| Cranial Nerve | Examination | Significance of Abnormalities |
|---|---|---|
| I (Olfactory) | Test smell with familiar odors (each nostril separately) | Anosmia: frontal lobe lesions, prior head trauma |
| II (Optic) | Visual acuity, visual fields, pupillary responses, fundoscopy | Papilledema: raised intracranial pressure; Visual field defects: localizing value; Optic atrophy: neurodegenerative, demyelinating |
| III, IV, VI (Oculomotor, Trochlear, Abducens) | Eye movements in all directions, ptosis, pupil responses | VI nerve palsy: raised intracranial pressure (false localizing); III nerve palsy: uncal herniation; Gaze abnormalities: brainstem or frontal lesions |
| V (Trigeminal) | Facial sensation, corneal reflex, jaw muscles | Sensory loss: brainstem lesion; Jaw weakness: myasthenia, motor neuron disease |
| VII (Facial) | Facial symmetry at rest and with movement, taste anterior tongue | Upper motor neuron pattern (forehead sparing): contralateral hemisphere lesion; Lower motor neuron pattern: peripheral lesion |
| VIII (Vestibulocochlear) | Hearing (whisper test, tuning fork), nystagmus | Hearing loss: acoustic neuroma (rare in children), congenital causes; Nystagmus: vestibular or central lesion |
| IX, X (Glossopharyngeal, Vagus) | Gag reflex, palate elevation, speech quality | Bulbar dysfunction: brainstem encephalitis, myasthenia |
| XI (Accessory) | Shoulder shrug, head turning against resistance | Weakness: posterior fossa or cervical lesions |
| XII (Hypoglossal) | Tongue protrusion, look for atrophy, fasciculations | Tongue deviation: contralateral hemisphere or ipsilateral brainstem; Atrophy/fasciculations: lower motor neuron lesion |
Motor Examination
Inspection
- Muscle bulk: atrophy, hypertrophy, asymmetry
- Fasciculations: lower motor neuron sign
- Involuntary movements: tremor, chorea, dystonia, tics, myoclonus, stereotypies
- Posture: abnormal posturing, asymmetry
Tone, Power, and Reflexes
- Tone: Increased (spasticity, rigidity) or decreased (hypotonia)
- Power: Test major muscle groups; grade 0-5; note pattern (proximal vs distal, upper vs lower)
- Reflexes: Biceps, triceps, brachioradialis, knee, ankle; note asymmetry, hyperreflexia, hyporeflexia
- Plantar response: Upgoing (Babinski) indicates upper motor neuron lesion
Movement Disorders to Identify
| Movement Type | Description | Associated Conditions |
|---|---|---|
| Chorea | Irregular, flowing, dance-like movements; cannot be suppressed | Sydenham chorea, autoimmune encephalitis, Huntington disease, Wilson disease, drug-induced |
| Dystonia | Sustained muscle contractions causing twisting, repetitive movements or abnormal postures | Autoimmune encephalitis, Wilson disease, metabolic disorders, medication effects |
| Tics | Sudden, rapid, recurrent, non-rhythmic movements or vocalizations; can be suppressed temporarily | Tourette syndrome, PANDAS, medication effects |
| Tremor | Rhythmic oscillation; note if present at rest, with action, or with intention | Rest tremor: parkinsonism; Intention tremor: cerebellar; Action tremor: essential tremor, hyperthyroidism, Wilson disease |
| Myoclonus | Sudden, brief, shock-like involuntary movements | Epilepsy (especially juvenile myoclonic epilepsy), metabolic encephalopathy, neurodegenerative disease |
| Orofacial Dyskinesias | Repetitive, stereotyped movements of face, tongue, jaw | Anti-NMDA receptor encephalitis (very characteristic), tardive dyskinesia |
| Stereotypies | Repetitive, seemingly purposeless movements (hand flapping, rocking) | Autism spectrum disorder, intellectual disability, Rett syndrome; distinguish from tics |
| Catatonia | Immobility, mutism, posturing, waxy flexibility, negativism, stereotyped movements | Autoimmune encephalitis (common), primary psychiatric conditions, metabolic disorders |
Coordination and Gait
- Finger-nose test: Dysmetria suggests cerebellar lesion
- Rapid alternating movements: Dysdiadochokinesis indicates cerebellar dysfunction
- Heel-shin test: Cerebellar function in lower limbs
- Romberg test: Posterior column/vestibular function
- Gait: Observe walking, heel-toe walking, running; note ataxia, spasticity, weakness pattern, involuntary movements
Sensory Examination
May be limited in younger children; assess light touch, pain, proprioception, vibration where cooperation allows. Sensory level suggests spinal cord pathology.
Systemic Examination
Cardiovascular
- Heart sounds: murmurs (endocarditis risk factor for embolic stroke, rheumatic heart disease associated with Sydenham chorea)
- Signs of heart failure: hepatomegaly, edema
- Peripheral pulses: asymmetry
Respiratory
- Signs of infection: consolidation, effusion
- Abnormal breathing patterns
- Signs of aspiration (in neurologically impaired)
Abdominal
- Hepatomegaly: Storage disorders, metabolic disease, Wilson disease
- Splenomegaly: Storage disorders, infection
- Masses: Neuroblastoma (paraneoplastic encephalitis)
- Abdominal pain: Porphyria, lead poisoning
Skin
- Neurocutaneous stigmata: Café-au-lait spots (neurofibromatosis), ash-leaf spots (tuberous sclerosis), port-wine stain (Sturge-Weber)
- Rashes: Vasculitis, lupus (malar rash), dermatomyositis
- Jaundice: Liver disease, Wilson disease
- Bruising: Coagulopathy, non-accidental injury
Expected Findings by Etiology
| Condition | General Examination | Neurological Findings | Key Distinguishing Features |
|---|---|---|---|
| Anti-NMDA Receptor Encephalitis | May appear well initially; later: fever, autonomic instability (tachycardia, blood pressure lability, hyperthermia) | Psychiatric symptoms, then seizures, orofacial dyskinesias, choreoathetosis, decreased consciousness, catatonia | Orofacial dyskinesias highly characteristic; progression from psychiatric to neurological; young females: consider ovarian teratoma |
| PANS/PANDAS | Often well-appearing; may have pharyngitis or recent streptococcal infection | Tics, choreiform movements, obsessive-compulsive behaviors, emotional lability, cognitive changes, handwriting deterioration | Acute, dramatic onset (“overnight”); obsessive-compulsive symptoms prominent; urinary symptoms; anxiety |
| Herpes Simplex Encephalitis | Fever, appears unwell | Altered consciousness, focal seizures (often temporal), aphasia, personality change, memory impairment, focal neurological signs | Fever with focal neurological signs; temporal lobe predilection; rapid progression; medical emergency |
| Brain Tumor | May appear well or cachectic; papilledema on fundoscopy | Signs depend on location: focal deficits, raised intracranial pressure signs, ataxia (posterior fossa), endocrine abnormalities (hypothalamic) | Symptoms often progressive; morning headache; vomiting without nausea; personality change may precede focal signs |
| Metabolic Encephalopathy | May have hepatomegaly, unusual odor, failure to thrive, coarse features (storage disorders) | Often diffuse encephalopathy without focal signs; may have movement disorder; episodic decompensation | Symptoms may worsen with illness or fasting; family history; developmental regression; multisystem involvement |
| Wilson Disease | Kayser-Fleischer rings (brownish corneal ring), hepatomegaly, jaundice | Tremor (often wing-beating), dystonia, dysarthria, drooling, gait abnormality, psychiatric symptoms | Adolescent onset; liver disease may precede or accompany neurological; Kayser-Fleischer rings diagnostic |
| Drug Intoxication/Toxicity | Vital sign abnormalities; pupil changes; skin findings (flushing, sweating) | Altered consciousness, agitation or sedation, seizures, movement abnormalities depend on substance | Acute onset; toxidrome patterns; pupil size and reactivity; vital sign abnormalities |
| Primary Psychiatric Disorder | Usually normal general examination; normal vital signs | Usually normal neurological examination; no focal signs; no movement disorder (except medication-induced) | Normal examination; preserved consciousness and orientation; auditory hallucinations more common than visual; chronic course often |
Important Teaching Point
Normal examination does not exclude organic disease! Many serious conditions causing behavioral changes in children may have few or no examination findings, especially early in the course. In particular:
- Early autoimmune encephalitis may present with only psychiatric symptoms and a normal examination
- Temporal lobe tumors may cause personality change with minimal focal signs
- Metabolic disorders may only manifest during decompensation
- Early encephalitis may precede development of fever or focal signs
Clinical pearl: A normal physical examination in a child with acute or atypical behavioral changes should increase suspicion for organic cause, not decrease it — it means the diagnosis cannot be made on examination alone and requires investigation.
Signs Requiring Immediate Action
Emergency Signs — Act Immediately
- Cushing’s triad: Hypertension, bradycardia, irregular respirations — raised intracranial pressure
- Papilledema: Raised intracranial pressure — do not perform lumbar puncture
- Unequal pupils or “blown pupil”: Impending herniation
- Decerebrate or decorticate posturing: Severe brain dysfunction
- Status epilepticus: Ongoing seizure activity
- Fever with meningism: Meningitis or encephalitis — urgent lumbar puncture (after imaging if signs of raised intracranial pressure)
- Severe autonomic instability: May indicate autoimmune encephalitis requiring intensive care
- Severe catatonia: May require intensive care monitoring
5. Differential Diagnosis
Systematic approach organized by probability, duration, and clinical features
The differential diagnosis of behavior or personality change in children is broad, spanning neurological, psychiatric, metabolic, infectious, toxic, and systemic etiologies. A systematic approach organized by probability and temporal profile helps prioritize investigation and ensures life-threatening conditions are not missed. The key clinical challenge is distinguishing primary psychiatric disorders from organic conditions that present with behavioral symptoms — a distinction with major implications for treatment and prognosis.
Fundamental Approach to Behavioral Change in Children:
- Step 1: Establish the timeline — Acute, subacute, or chronic onset determines the most likely etiologies
- Step 2: Identify red flags — Features suggesting organic cause (see History section)
- Step 3: Consider the “Big Five” organic causes — Autoimmune encephalitis, infection, tumor, metabolic disorder, toxins/drugs
- Step 4: Systematic investigation — Even if psychiatric diagnosis seems likely, exclude organic causes in atypical presentations
- Step 5: Reassess — If treatment response is poor or atypical, reconsider organic causes
Acute Behavioral Change (Hours to Days)
Acute onset of behavioral change is a medical emergency until proven otherwise. Organic causes are more likely than primary psychiatric disorders in this timeframe.
| Probability | Condition | Key Features | Red Flags / Distinguishing Features |
|---|---|---|---|
| COMMON | Delirium (from any cause) | Fluctuating consciousness, inattention, disorientation, agitation or lethargy, visual hallucinations | Altered level of consciousness; waxing and waning; worse at night; underlying medical illness |
| Drug intoxication or adverse effect | Variable depending on substance; altered consciousness, agitation or sedation, vital sign abnormalities | Access to medications or substances; recent medication changes; toxidrome pattern; pupil abnormalities | |
| Postictal state | Confusion, aggression, psychosis following seizure; may last hours | History of seizure disorder; witnessed convulsion; gradual resolution; Todd’s paralysis | |
| Acute stress reaction / Adjustment disorder | Behavioral change following identifiable stressor; anxiety, withdrawal, regression | Clear precipitant; normal neurological examination; preserved consciousness; no red flags | |
| LESS COMMON | Infectious encephalitis | Fever, headache, altered consciousness, personality change, seizures, focal signs | Fever; rapid progression; focal neurological signs; meningism; prodromal illness |
| Metabolic encephalopathy | Confusion, lethargy, irritability; may have vomiting, seizures | Hypoglycemia, electrolyte disturbance, hepatic/renal failure; inborn errors during metabolic stress | |
| Traumatic brain injury | Behavioral change following head trauma; irritability, aggression, confusion | History of trauma (may be occult in non-accidental injury); consider subdural hematoma | |
| UNCOMMON BUT SERIOUS | Intracranial hemorrhage | Sudden severe headache, altered consciousness, vomiting, focal signs | Thunderclap headache; rapid deterioration; hypertension; coagulopathy; vascular malformation |
| Non-convulsive status epilepticus | Prolonged confusion, behavioral change, subtle motor signs without obvious convulsion | Fluctuating course; subtle eye movements or automatisms; history of epilepsy; requires EEG to diagnose | |
| Acute hydrocephalus | Headache, vomiting, altered consciousness, personality change, gait disturbance | Morning symptoms; papilledema; shunt malfunction in patients with shunts; upgaze palsy | |
| Pediatric stroke | Acute focal deficits; may present with behavioral change especially with frontal or limbic involvement | Sudden onset; focal signs; risk factors (cardiac disease, sickle cell, vasculitis) |
Subacute Behavioral Change (1-4 Weeks)
Subacute onset is particularly concerning for autoimmune and inflammatory conditions. This is the classic timeframe for autoimmune encephalitis, PANS/PANDAS, and evolving infections.
| Probability | Condition | Key Features | Red Flags / Distinguishing Features |
|---|---|---|---|
| COMMON | Autoimmune encephalitis (including Anti-NMDA receptor encephalitis) | Psychiatric symptoms (psychosis, personality change, catatonia), seizures, movement disorders, autonomic instability, sleep disturbance | Progression from psychiatric to neurological; orofacial dyskinesias; autonomic instability; young females (ovarian teratoma); fluctuating course |
| PANS / PANDAS | Acute dramatic onset of obsessive-compulsive symptoms, anxiety, tics, emotional lability, cognitive changes, urinary symptoms, sleep disturbance | “Overnight” onset; preceding streptococcal or other infection; OCD and anxiety prominent; movement abnormalities; age 3-puberty | |
| Post-infectious encephalopathy | Behavioral and cognitive changes following viral illness; may be subacute onset | Clear preceding infection; autoimmune mechanism; may respond to immunotherapy | |
| LESS COMMON | Sydenham chorea | Chorea, emotional lability, obsessive-compulsive symptoms, hypotonia, motor impersistence | Post-streptococcal; chorea may be subtle initially; milkmaid’s grip; darting tongue; peaks months after strep infection |
| Subacute viral encephalitis | Progressive encephalopathy, personality change, cognitive decline, seizures | May lack fever; consider Epstein-Barr virus, human herpesvirus 6, enterovirus; immunocompromised at higher risk | |
| Brain tumor (early presentation) | Progressive personality change, headaches, focal symptoms depending on location | Morning headache; vomiting; visual symptoms; focal neurological signs; papilledema | |
| Drug-induced behavioral change | Behavioral symptoms temporally related to medication initiation or dose change | Corticosteroids; antiepileptic drugs; stimulants; montelukast; temporal relationship to medication | |
| UNCOMMON BUT SERIOUS | CNS vasculitis | Headache, cognitive decline, focal deficits, behavioral change, seizures, stroke-like episodes | Multifocal; stroke-like episodes in young patient; systemic vasculitis features; elevated inflammatory markers |
| Paraneoplastic encephalitis | Behavioral change, limbic symptoms, movement disorders; associated with occult malignancy | Consider neuroblastoma (opsoclonus-myoclonus), ovarian teratoma (anti-NMDA receptor); systemic symptoms | |
| Hashimoto encephalopathy | Cognitive decline, behavioral change, seizures, stroke-like episodes, myoclonus, psychosis | Elevated anti-thyroid antibodies; may have normal thyroid function; steroid-responsive |
Chronic/Insidious Behavioral Change (Greater Than 4 Weeks)
Chronic onset broadens the differential to include neurodegenerative conditions, slow-growing tumors, and primary psychiatric disorders. However, organic causes must still be excluded, particularly in atypical presentations.
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Primary psychiatric disorders (depression, anxiety, emerging bipolar, early schizophrenia) | Most common cause overall | Normal neurological examination; preserved consciousness; family psychiatric history; response to psychiatric treatment; age-appropriate onset |
| Attention-deficit/hyperactivity disorder | 5-10% of children | Symptoms present before age 12; pervasive across settings; no regression; response to stimulants | |
| Autism spectrum disorder (new recognition or regression) | 1-2% of children | Social communication deficits; restricted interests; early childhood onset; developmental trajectory abnormal from early life in most cases | |
| Substance use disorder | Common in adolescents | Adolescent age group; secrecy; peer group changes; physical signs of intoxication or withdrawal; toxicology positive | |
| Chronic sleep deprivation | Common, often overlooked | Insufficient sleep quantity or quality; mood and behavioral improvement with adequate sleep; screen time often implicated | |
| LESS COMMON | Brain tumor | 2-5 per 100,000 children annually | Progressive symptoms; focal neurological signs; raised intracranial pressure signs; abnormal neuroimaging |
| Epilepsy-related behavioral disturbance | Behavioral problems in 30-40% of children with epilepsy | History of seizures; may be interictal, ictal, or medication-related; EEG abnormalities | |
| Thyroid disorders | Varies | Hypothyroidism: fatigue, cognitive slowing, depression; Hyperthyroidism: anxiety, hyperactivity, irritability; thyroid abnormalities on examination/labs | |
| Chronic lead poisoning | Varies by region | Learning difficulties, behavioral problems, abdominal pain; environmental exposure history; elevated blood lead level | |
| UNCOMMON BUT SERIOUS | Wilson disease | 1 in 30,000 | Adolescent onset; tremor, dystonia, dysarthria; psychiatric symptoms may precede neurological; Kayser-Fleischer rings; liver disease |
| Neurodegenerative diseases (Huntington disease, NCL, adrenoleukodystrophy, mitochondrial disorders) | Rare individually | Progressive decline; developmental regression; movement disorders; family history; white matter or basal ganglia changes on MRI | |
| Inborn errors of metabolism (urea cycle, organic acidurias, homocystinuria) | Rare individually | May have episodic decompensation; developmental issues; dietary triggers; multisystem involvement; abnormal metabolic screening | |
| Subacute sclerosing panencephalitis | Very rare (due to vaccination) | History of measles; progressive cognitive decline, myoclonus, seizures; characteristic EEG; elevated measles antibodies in CSF | |
| HIV encephalopathy | Rare in developed countries | Risk factors for HIV; developmental regression; motor abnormalities; systemic features |
Anatomical Approach to Differential Diagnosis
Considering the anatomical localization of symptoms can help narrow the differential and guide investigation.
Frontal Lobe / Prefrontal
Symptoms: Personality change, disinhibition, impulsivity, apathy, executive dysfunction, social inappropriateness
Consider:
• Frontal lobe tumors
• Traumatic brain injury
• Frontotemporal dementia (rare in children)
• Autoimmune encephalitis
• Frontal lobe epilepsy
Temporal Lobe / Limbic
Symptoms: Memory impairment, emotional changes, hallucinations, personality change, seizures, behavioral automatisms
Consider:
• Limbic encephalitis (autoimmune)
• Herpes simplex encephalitis
• Temporal lobe epilepsy
• Temporal lobe tumors
• Anti-NMDA receptor encephalitis
Basal Ganglia
Symptoms: Movement disorders (chorea, dystonia, tics), obsessive-compulsive symptoms, mood changes, cognitive slowing
Consider:
• PANDAS / Sydenham chorea
• Wilson disease
• Huntington disease
• Autoimmune encephalitis
• Basal ganglia tumors
• Neurometabolic disorders
Hypothalamic / Diencephalic
Symptoms: Sleep disturbance, appetite changes, temperature dysregulation, endocrine abnormalities, personality change, rage attacks
Consider:
• Hypothalamic tumors (craniopharyngioma, glioma)
• Autoimmune encephalitis
• Diencephalic syndrome
• Kleine-Levin syndrome
• Langerhans cell histiocytosis
Age-Specific Differential Considerations
| Age Group | Conditions More Common at This Age | Key Considerations |
|---|---|---|
| Infants (0-1 year) | Inborn errors of metabolism, congenital infections, non-accidental injury, infantile spasms, early infantile epileptic encephalopathy | Limited behavioral repertoire makes assessment difficult; irritability and feeding problems may be only signs; developmental regression is always concerning |
| Toddlers (1-3 years) | Autism spectrum disorder presentation, Landau-Kleffner syndrome, lead poisoning, post-infectious encephalopathy, early-onset epilepsy | Language regression particularly concerning; distinguish autism from acquired regression; ingestion of toxins more common at this age |
| Preschool (3-5 years) | PANS/PANDAS (peak onset), brain tumors (especially posterior fossa), early ADHD, adjustment disorders | PANDAS more common than anti-NMDA receptor encephalitis at this age; dramatic overnight onset of OCD highly suggestive |
| School-age (6-12 years) | PANS/PANDAS, absence epilepsy, brain tumors, ADHD presentation, learning disabilities, Sydenham chorea | Academic decline may be first sign; absence seizures may present as “daydreaming” or behavioral change; Sydenham chorea peaks in this age group |
| Adolescents (12-18 years) | Anti-NMDA receptor encephalitis, Wilson disease, substance abuse, primary psychiatric disorders (schizophrenia, bipolar onset), brain tumors | Always consider substance abuse; anti-NMDA receptor encephalitis more common than PANDAS; first presentation of schizophrenia or bipolar possible but must exclude organic causes |
Drug-Induced Behavioral Changes
| Drug or Drug Class | Behavioral Effects | Mechanism | Time Course |
|---|---|---|---|
| Corticosteroids | Mood lability, euphoria, depression, psychosis, mania, insomnia, aggression | Effects on glucocorticoid receptors in limbic system; altered neurotransmitter function | Often within first weeks; dose-related; may persist after discontinuation |
| Levetiracetam | Irritability, aggression, behavioral disinhibition, depression, psychosis (rare) | Mechanism not fully understood; may relate to SV2A binding | Usually within first weeks to months; often improves with dose reduction |
| Topiramate | Cognitive slowing, word-finding difficulty, depression, anxiety | Carbonic anhydrase inhibition; multiple receptor effects | Often early in treatment; dose-related; “dopamax” effect |
| Phenobarbital | Hyperactivity, behavioral disinhibition, paradoxical excitement (especially in children) | GABAergic effects; paradoxical disinhibition in developing brain | May develop gradually; often persistent while on medication |
| Stimulants (methylphenidate, amphetamines) | Irritability, emotional blunting, mood lability, rare psychosis at high doses | Increased dopamine and norepinephrine | Often dose-related; may occur at therapeutic doses |
| Montelukast | Agitation, aggression, anxiety, depression, sleep disturbance, suicidal thoughts (rare) | Uncertain; may cross blood-brain barrier and affect leukotriene receptors in CNS | Variable; FDA black box warning |
| Antihistamines | Paradoxical excitation, irritability, hyperactivity (especially in young children) | Anticholinergic effects; paradoxical in developing brain | Acute; more common in younger children |
| Beta-agonists (salbutamol, etc.) | Hyperactivity, tremor, sleep disturbance, irritability | Beta-adrenergic stimulation; CNS penetration | Often with acute use; dose-related |
| Isotretinoin | Depression, mood changes, rarely psychosis or suicidal ideation | Effects on retinoid receptors in brain; controversial | May develop over weeks to months |
| Fluoroquinolones | Confusion, anxiety, insomnia, depression, rarely psychosis | GABA receptor antagonism; excitatory effects | Usually within days of starting; resolves with discontinuation |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Key Diagnostic Step |
|---|---|---|
| Overnight onset of OCD + tics + emotional lability in child | PANS / PANDAS | Anti-streptolysin O, anti-DNase B titers; throat culture; consider autoimmune encephalitis panel |
| Psychiatric symptoms → seizures → movement disorder in adolescent female | Anti-NMDA receptor encephalitis | CSF anti-NMDA receptor antibodies; MRI brain; pelvic ultrasound for ovarian teratoma |
| Orofacial dyskinesias with behavioral change | Anti-NMDA receptor encephalitis | CSF analysis with antibody panel; highly characteristic finding |
| Chorea + emotional lability weeks after sore throat | Sydenham chorea | Anti-streptolysin O, anti-DNase B titers; echocardiogram for carditis |
| Personality change + tremor + liver abnormalities in adolescent | Wilson disease | Ceruloplasmin, 24-hour urine copper; slit lamp for Kayser-Fleischer rings |
| Morning headaches + vomiting + personality change | Brain tumor with raised intracranial pressure | Urgent MRI brain with contrast |
| Fever + confusion + seizures | Infectious encephalitis (HSV until proven otherwise) | Urgent LP (if no contraindication); HSV PCR; start acyclovir empirically |
| Episodic confusion with return to baseline | Seizure-related (temporal lobe epilepsy or absence status) | EEG (prolonged or video-EEG if possible) |
| Behavioral change after starting new medication | Drug-induced behavioral change | Trial of discontinuation or dose reduction if safe |
| Developmental regression in toddler | Autism with regression, Landau-Kleffner, metabolic disorder, Rett syndrome (if female) | Sleep EEG (Landau-Kleffner); metabolic screen; genetic testing; MRI |
| Progressive cognitive decline + movement disorder | Neurodegenerative disease (Wilson, Huntington, NCL, leukodystrophy) | MRI brain; ceruloplasmin; genetic testing; consider specialized metabolic studies |
| Behavioral change in adolescent with peer group changes, secrecy | Substance abuse | Urine drug screen; confidential interview with adolescent alone |
Clinical Pearl: The “Rule of Thumb” for Organic vs Psychiatric
While overlap exists, certain features favor organic causes over primary psychiatric disorders:
- Acute onset (hours to days) favors organic
- Visual hallucinations favor organic (auditory are more common in psychiatric)
- Altered consciousness or orientation strongly favors organic
- Abnormal neurological examination indicates organic cause
- Atypical age for the suspected psychiatric diagnosis should prompt organic workup
- Poor response to psychiatric treatment should prompt reconsideration of organic causes
- Fluctuating course is more common in organic conditions
However: Normal examination does NOT exclude organic disease. When in doubt, investigate.
6. Diagnostic Investigations
A stepwise, targeted approach guided by clinical suspicion
Investigation of behavioral change in children should be guided by clinical suspicion based on history and examination, while also ensuring that serious treatable conditions are not missed. The threshold for investigation should be lower in children with acute or subacute onset, atypical features, or poor response to psychiatric treatment. A stepwise approach helps balance thoroughness with cost-effectiveness, but in urgent presentations, multiple investigations may be needed simultaneously.
Guiding Principles for Investigation:
- Urgent presentations (altered consciousness, fever, seizures, rapid progression) require immediate comprehensive workup
- Subacute presentations with red flags warrant thorough investigation before concluding primary psychiatric diagnosis
- Even “typical” psychiatric presentations may warrant baseline investigations to exclude organic causes
- Negative initial workup does not exclude organic disease — repeat or expand investigation if clinical picture is atypical or treatment response is poor
Baseline Investigations for All Patients with Significant Behavioral Change
These investigations should be considered in any child with unexplained significant behavioral change, particularly with acute or subacute onset, to screen for common and treatable causes.
| Investigation | Purpose | What to Look For | Pediatric Considerations |
|---|---|---|---|
| Complete blood count | Screen for infection, inflammation, anemia, malignancy | Leukocytosis (infection); lymphocytosis (viral); anemia (chronic disease); abnormal cells (leukemia) | Normal ranges vary by age; know pediatric reference values |
| Comprehensive metabolic panel | Electrolytes, glucose, renal and liver function | Hyponatremia, hypoglycemia, hypercalcemia, elevated ammonia precursors, liver dysfunction | Hypoglycemia more common in children; include glucose in all workups |
| Thyroid function tests (TSH, free T4) | Screen for hyper/hypothyroidism | Hypothyroidism: depression, cognitive slowing; Hyperthyroidism: anxiety, hyperactivity | Autoimmune thyroid disease can coexist with autoimmune encephalitis |
| Inflammatory markers (CRP, ESR) | Screen for inflammatory/infectious process | Elevation suggests infection, inflammation, autoimmune process, or malignancy | May be normal in autoimmune encephalitis; absence does not exclude inflammation |
| Urinalysis | Screen for infection, metabolic disease | UTI (can cause delirium in children); ketones; abnormal metabolites | UTI more common cause of behavioral change in young children than often recognized |
| Urine drug screen | Screen for substance use or accidental ingestion | Presence of drugs of abuse, medications, toxins | Consider in all adolescents; in younger children, consider accidental ingestion |
| Ammonia level | Screen for urea cycle disorders, liver failure | Elevation suggests urea cycle defect, liver failure, certain organic acidemias | Sample handling critical — must be placed on ice and processed rapidly; false positives common |
Second-Tier Investigations Based on Clinical Suspicion
If Suspecting Autoimmune Encephalitis
Autoimmune encephalitis should be considered in any child with subacute onset behavioral change, especially with psychiatric symptoms, seizures, movement disorders, or autonomic instability.
Essential Investigations
- MRI brain with contrast: May show T2/FLAIR hyperintensity in medial temporal lobes, basal ganglia, or be normal (normal MRI does not exclude autoimmune encephalitis)
- Lumbar puncture with CSF analysis:
- Cell count (lymphocytic pleocytosis common)
- Protein (may be mildly elevated)
- Glucose (usually normal)
- Oligoclonal bands (may be present)
- CSF autoimmune encephalitis antibody panel (send to specialized lab)
- Serum autoimmune encephalitis antibody panel: Include anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-GABA-B, anti-AMPA, others
- EEG: May show diffuse slowing, extreme delta brush (characteristic of anti-NMDA receptor encephalitis), or seizure activity
Additional Investigations
- Pelvic ultrasound (females): Screen for ovarian teratoma (associated with anti-NMDA receptor encephalitis)
- CT chest/abdomen/pelvis: If paraneoplastic syndrome suspected
- Anti-thyroid antibodies: For Hashimoto encephalopathy
- Voltage-gated potassium channel complex antibodies
- Note: Antibodies may be negative initially; if clinical suspicion high, repeat testing or treat empirically
CSF vs Serum Antibodies in Autoimmune Encephalitis
CSF testing is more sensitive for most autoimmune encephalitis antibodies, particularly anti-NMDA receptor antibodies. Up to 14% of patients with anti-NMDA receptor encephalitis may be serum-negative but CSF-positive. Therefore:
- Always send CSF antibody panel when autoimmune encephalitis is suspected
- Serum testing alone is insufficient to exclude the diagnosis
- If initial testing is negative but clinical suspicion remains high, consider repeat testing or empiric treatment
If Suspecting PANS/PANDAS
First-Line Tests
- Anti-streptolysin O (ASO) titer: Elevated suggests recent streptococcal infection (peaks 3-6 weeks post-infection)
- Anti-DNase B titer: More sensitive for streptococcal skin infections; remains elevated longer than ASO
- Throat culture: For group A streptococcus (even if asymptomatic carriage)
- Rapid strep test: Less sensitive than culture
Additional Considerations
- Mycoplasma pneumoniae IgM and IgG: Mycoplasma associated with PANS
- Consider autoimmune encephalitis panel: To exclude overlap syndromes
- Brain MRI: Usually normal; helpful to exclude other pathology
- Note: Diagnosis is primarily clinical; negative strep titers do not exclude PANS (only PANDAS requires streptococcal association)
If Suspecting Infectious Encephalitis
Urgent Investigations
- Lumbar puncture (unless contraindicated by raised intracranial pressure signs):
- Cell count, protein, glucose
- Gram stain and bacterial culture
- HSV PCR (essential — do not wait for results to start acyclovir)
- Enterovirus PCR
- VZV PCR and IgM
- MRI brain with contrast: May show temporal lobe involvement (HSV), diffuse changes, or specific patterns
- EEG: May show focal slowing, periodic lateralized epileptiform discharges (PLEDs) in HSV
Additional Pathogen Testing (Based on Clinical Context)
- Epstein-Barr virus: Serology and CSF PCR
- Human herpesvirus 6: CSF PCR (especially in immunocompromised)
- Cytomegalovirus: CSF PCR (immunocompromised)
- Arboviruses: Based on geographic exposure (West Nile, Eastern equine encephalitis, etc.)
- Tuberculosis: CSF studies, chest X-ray, tuberculin skin test/interferon-gamma release assay
- Lyme disease: If endemic area and appropriate exposure
Critical Point: Herpes Simplex Encephalitis
HSV encephalitis is a medical emergency. If there is any clinical suspicion (fever + behavioral change + altered consciousness, especially with focal features):
- Start IV acyclovir immediately — do not wait for CSF results
- HSV PCR may be negative in first 24-72 hours — repeat if initially negative and suspicion remains
- Early treatment dramatically improves outcomes
- Delayed treatment leads to permanent brain damage or death
If Suspecting Brain Tumor or Structural Lesion
Primary Investigation
- MRI brain with and without contrast: Gold standard for detecting tumors, structural abnormalities
- Include T1, T2, FLAIR, DWI, post-contrast sequences
- Consider MR spectroscopy if tumor suspected
- If MRI not immediately available and urgent: CT head with contrast can identify most significant lesions
Additional Studies
- If hypothalamic lesion: Full endocrine workup (pituitary hormones, growth hormone, cortisol, thyroid)
- Visual fields: If lesion near optic pathway
- Fundoscopy: For papilledema (raised intracranial pressure)
- Tumor markers: AFP, beta-hCG for germ cell tumors
If Suspecting Metabolic Disorder
| Test | What It Screens For | When to Order | Interpretation Notes |
|---|---|---|---|
| Ammonia | Urea cycle disorders, organic acidemias, liver failure | Acute encephalopathy, especially with vomiting; episodic symptoms | Collect on ice, process immediately; values >100 μmol/L concerning |
| Lactate (plasma and CSF) | Mitochondrial disorders, metabolic stress | Developmental regression, episodic symptoms, multisystem involvement | Avoid tourniquet/struggling; CSF lactate may be elevated when plasma is normal in mitochondrial disease |
| Plasma amino acids | Aminoacidopathies, urea cycle disorders | Developmental regression, episodic encephalopathy, dietary triggers | Fasting sample preferred; specific patterns suggest specific disorders |
| Urine organic acids | Organic acidemias | Episodic encephalopathy, metabolic acidosis, unusual odor | Best collected during acute illness if episodic |
| Acylcarnitine profile | Fatty acid oxidation defects, organic acidemias | Episodic symptoms with fasting, hypoglycemia, cardiomyopathy | May be normal between episodes |
| Homocysteine | Homocystinuria | Marfanoid habitus, lens dislocation, thrombosis, cognitive decline | Total plasma homocysteine; may need methionine level as well |
| Very long chain fatty acids | X-linked adrenoleukodystrophy | Boys with behavioral/cognitive decline, adrenal insufficiency, white matter changes | Also screens for other peroxisomal disorders |
If Suspecting Wilson Disease
First-Line Tests
- Ceruloplasmin: Low in most cases of Wilson disease (<20 mg/dL suggestive; <14 mg/dL highly suggestive)
- 24-hour urine copper: Elevated (>100 μg/24h suspicious; >40 μg/24h in children)
- Slit lamp examination: For Kayser-Fleischer rings (present in >95% with neurological Wilson disease)
- Liver function tests: May show hepatitis pattern or cirrhosis
Confirmatory Tests
- Serum copper: Often low (bound copper); “free” copper elevated
- Liver biopsy with copper quantification: Gold standard (>250 μg/g dry weight diagnostic)
- ATP7B genetic testing: Identifies mutations in Wilson disease gene
- MRI brain: May show “face of the giant panda” sign in midbrain, basal ganglia abnormalities
If Suspecting Seizure-Related Behavioral Change
EEG Studies
- Routine EEG: May capture interictal abnormalities; limited sensitivity for brief or infrequent events
- Prolonged or ambulatory EEG: Better for capturing infrequent events
- Video-EEG monitoring: Gold standard for correlating behavior with EEG changes
- Sleep-deprived EEG: May increase yield for some epilepsies
- Overnight EEG with sleep: Essential if considering Landau-Kleffner syndrome (sleep-activated epileptiform activity)
Additional Studies
- MRI brain: To identify structural cause of epilepsy
- Consider genetic testing: For epilepsy gene panels in certain presentations
- Neuropsychological testing: To assess cognitive impact
Lumbar Puncture: When and How
Lumbar puncture with CSF analysis is a key investigation in many causes of behavioral change, particularly autoimmune and infectious encephalitis.
| Indication | Contraindications (Require Imaging First) | CSF Studies to Order |
|---|---|---|
|
|
|
Neuroimaging: MRI vs CT
| Modality | Advantages | Limitations | When to Use |
|---|---|---|---|
| MRI Brain | Superior soft tissue contrast; no radiation; better for encephalitis, tumors, demyelination, metabolic disorders | Longer scan time; may require sedation in young children; less available urgently; contraindicated with some implants | Preferred modality for most non-emergency situations; essential for autoimmune encephalitis workup |
| CT Head | Rapid; widely available; good for hemorrhage, hydrocephalus, large masses; no sedation usually needed | Radiation exposure; limited soft tissue detail; may miss early encephalitis, small tumors | Emergency situations; to rule out contraindications to LP; when MRI not available or patient unstable |
Pediatric Neuroimaging Considerations
- Sedation: Children under 6-8 years often require sedation or general anesthesia for MRI; this requires additional planning and monitoring
- Radiation: CT exposes children to ionizing radiation; use judiciously, but do not delay necessary imaging
- Feed-and-sleep MRI: In infants, feeding and allowing natural sleep may avoid sedation
- Motion artifact: Movement degrades image quality; ensure child is adequately prepared or sedated
- Developmental changes: Normal brain MRI appearance changes with age (myelination patterns); radiologist should be familiar with pediatric imaging
EEG: Interpretation in Behavioral Change
| EEG Finding | Clinical Significance | Associated Conditions |
|---|---|---|
| Diffuse slowing | Non-specific; indicates diffuse cerebral dysfunction | Encephalopathy of any cause, metabolic disturbance, medication effects, post-ictal |
| Focal slowing | Suggests focal cerebral dysfunction | Tumor, stroke, focal encephalitis, post-ictal (Todd’s phenomenon) |
| Extreme delta brush | Highly characteristic pattern; rhythmic delta with superimposed beta | Anti-NMDA receptor encephalitis (seen in ~30% of cases) |
| Periodic lateralized epileptiform discharges (PLEDs) | Periodic sharp waves, often with focal slowing | Herpes simplex encephalitis (temporal), acute stroke, tumor |
| Continuous spike-wave during slow sleep (CSWS) | Near-continuous spike-wave activity during non-REM sleep | Landau-Kleffner syndrome, epileptic encephalopathy with CSWS; language and cognitive regression |
| Generalized spike-wave | Generalized epileptiform activity | Absence epilepsy, other generalized epilepsies |
| Temporal epileptiform activity | Focal spikes or sharp waves in temporal region | Temporal lobe epilepsy (behavioral automatisms, memory symptoms) |
Empiric Treatment as Diagnostic Tool
Treatment Trials in Uncertain Cases
In some situations, response to empiric treatment supports a diagnosis:
- Acyclovir for suspected HSV encephalitis: Start empirically if any suspicion; do not wait for PCR results
- Antibiotics for suspected PANDAS: If acute onset OCD/tics with elevated strep titers, antibiotic treatment (and improvement) supports the diagnosis
- Immunotherapy for suspected autoimmune encephalitis: In strong clinical cases with pending antibody results, empiric steroids or IVIG may be started; response supports diagnosis
- Medication discontinuation: If drug-induced behavioral change suspected, discontinuation with improvement supports the diagnosis
- Antiepileptic drugs: In suspected seizure-related behavioral change, response to antiepileptic medication supports the diagnosis
Caution: Treatment response should be interpreted carefully; some conditions may fluctuate naturally, and placebo response is possible.
Summary: Stepwise Investigation Approach
Tier 1 (All significant presentations):
- Complete blood count, metabolic panel, thyroid function, inflammatory markers, urinalysis, urine drug screen, ammonia
Tier 2 (Based on clinical suspicion):
- Neuroimaging: MRI brain with contrast (preferred) or CT if urgent
- EEG: Routine or prolonged, based on suspected seizure activity
- Lumbar puncture: If infection or autoimmune encephalitis suspected (with appropriate CSF studies)
Tier 3 (Targeted testing):
- Autoimmune encephalitis antibody panel (serum and CSF)
- Streptococcal titers (ASO, anti-DNase B) for PANS/PANDAS
- Specific infectious serology/PCR based on exposure
- Metabolic studies for inborn errors
- Wilson disease workup in adolescents
- Genetic testing as indicated
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for behavior or personality change
Clinical decision-making in pediatric behavioral change requires balancing the urgency of excluding life-threatening conditions against the reality that most cases will ultimately have benign or psychiatric etiologies. This section provides practical frameworks for triage, investigation, and management decisions based on clinical presentation patterns.
Step 1: Is This Urgent?
The first and most critical decision is determining the urgency of the presentation. This guides the speed and intensity of investigation and the need for immediate intervention.
| Clinical Scenario | Urgency Level | Immediate Actions | Disposition |
|---|---|---|---|
| Altered consciousness + fever | EMERGENT | ABCs, IV access, blood cultures, start IV acyclovir and antibiotics empirically, urgent CT then LP (if safe), urgent MRI when stable | Immediate admission to PICU or high-dependency unit |
| Signs of raised intracranial pressure (papilledema, Cushing triad, new focal deficits with headache) | EMERGENT | ABCs, elevate head of bed, urgent CT head, neurosurgical consultation, do NOT perform LP | Immediate admission; may need emergency surgery |
| Status epilepticus or ongoing seizures | EMERGENT | ABCs, benzodiazepines, seizure protocol, check glucose, consider causes | PICU if prolonged; ward if quickly controlled |
| Severe autonomic instability (extreme tachycardia, blood pressure swings, hyperthermia) | EMERGENT | Stabilization, cooling if hyperthermic, cardiac monitoring, consider autoimmune encephalitis or intoxication | PICU admission for monitoring |
| Acute psychosis with risk to self or others | URGENT | Ensure safety, 1:1 supervision, medical workup to exclude organic cause, psychiatric consultation | Admission; medical vs psychiatric unit depends on organic workup |
| Subacute behavioral change with neurological signs (movement disorder, seizures, focal deficits) | URGENT | Comprehensive neurological workup including MRI, EEG, LP; consider autoimmune encephalitis panel | Admission for expedited workup |
| Acute-onset OCD/tics/anxiety in previously well child (PANS/PANDAS pattern) | URGENT | Strep testing, consider autoimmune panel, early treatment may improve outcomes | Can often be outpatient if safe; admission if severe |
| Catatonia (immobility, mutism, posturing) | URGENT | Medical workup for autoimmune encephalitis; monitor for malignant catatonia; consider lorazepam challenge | Admission; may need PICU if autonomic instability develops |
| Gradual behavioral change without red flags | SEMI-URGENT | Thorough history and examination, baseline investigations, consider outpatient MRI and EEG | Often outpatient workup appropriate if safe and stable |
| Chronic behavioral concerns, typical psychiatric presentation | ROUTINE | Psychiatric evaluation, consider baseline investigations, neurological referral if atypical features | Outpatient; psychiatric follow-up |
Step 2: Classify by Duration and Pattern
Acute (Hours to Days)
Assume organic cause until proven otherwise
Proceed to Emergency Algorithm
- Infectious workup
- Metabolic screen
- Toxicology
- Neuroimaging
Subacute (1-4 Weeks)
High suspicion for autoimmune or inflammatory causes
Proceed to Autoimmune Algorithm
- MRI brain
- EEG
- LP with antibody panel
- Strep titers
Chronic (>4 Weeks)
Broader differential; exclude organic before psychiatric diagnosis
Proceed to Comprehensive Algorithm
- Baseline labs
- MRI if not done
- Consider EEG
- Psychiatric evaluation
Step 3: Decision Algorithms by Presentation
Algorithm A: Acute Behavioral Change (Emergency Pathway)
| Clinical Scenario | Most Likely Diagnoses | Immediate Actions | Key Investigations |
|---|---|---|---|
| Fever + altered consciousness + behavioral change | Infectious encephalitis (HSV until proven otherwise), bacterial meningitis, sepsis with encephalopathy | IV acyclovir + antibiotics immediately; do not wait for results | LP (if safe), HSV PCR, MRI, blood cultures, metabolic panel |
| Known ingestion or suspected intoxication | Drug intoxication, poisoning | Supportive care, specific antidotes if available, poison control consultation | Urine and serum toxicology, specific drug levels, metabolic panel |
| Post-seizure confusion > 30 minutes | Prolonged postictal state, non-convulsive status epilepticus, underlying structural lesion | EEG to exclude ongoing seizure activity; neuroimaging | EEG (urgent), CT or MRI, metabolic panel |
| Acute confusion with no obvious cause | Delirium (multiple causes), metabolic encephalopathy, intoxication, early encephalitis, non-convulsive seizures | Broad workup; treat empirically for serious causes | Full metabolic panel, ammonia, toxicology, EEG, neuroimaging, consider LP |
| Head trauma + behavioral change | Concussion, intracranial hemorrhage, diffuse axonal injury | CT head urgently; neurosurgical consultation if hemorrhage | CT head (immediate), consider MRI later, serial neurological exams |
Algorithm B: Subacute Behavioral Change (Autoimmune Pathway)
| Clinical Scenario | Most Likely Diagnoses | Initial Management | Key Investigations |
|---|---|---|---|
| Psychiatric symptoms → seizures → movement disorder (especially in female adolescent) | Anti-NMDA receptor encephalitis | Admit; start immunotherapy early if high clinical suspicion; tumor screening | CSF antibody panel (critical), MRI, EEG, pelvic ultrasound (teratoma) |
| Overnight onset OCD + tics + anxiety in child | PANS/PANDAS | Strep treatment if positive; consider immunomodulatory therapy if severe | ASO, anti-DNase B, throat culture, consider autoimmune panel if severe |
| Chorea + emotional lability (weeks after infection) | Sydenham chorea | Penicillin prophylaxis; symptomatic treatment for chorea; echocardiogram | ASO, anti-DNase B, echocardiogram (for carditis), MRI brain |
| Behavioral change + memory problems + sleep disturbance | Limbic encephalitis (various antibodies) | LP with antibody panel; consider empiric immunotherapy | MRI (temporal lobe signal), EEG, CSF/serum antibody panel |
| Psychiatric symptoms with poor response to medications | Autoimmune encephalitis misdiagnosed as psychiatric | Reconsider organic causes; autoimmune workup | MRI, EEG, LP with antibody panel, even if prior workup was negative |
Algorithm C: Chronic/Insidious Behavioral Change
| Clinical Scenario | Most Likely Diagnoses | Approach | Key Investigations |
|---|---|---|---|
| Gradual personality change + headaches + academic decline | Brain tumor, hydrocephalus, chronic subdural (consider abuse in young children) | Neuroimaging essential before psychiatric diagnosis | MRI brain with contrast |
| Adolescent with tremor + psychiatric symptoms + dysarthria | Wilson disease | Wilson workup in ALL adolescents with unexplained neuropsychiatric symptoms | Ceruloplasmin, 24-hour urine copper, slit lamp, LFTs |
| Progressive cognitive decline + movement disorder | Neurodegenerative disease (Huntington, NCL, leukodystrophy, mitochondrial) | Metabolic and genetic workup; family history review | MRI, genetic testing, metabolic screen, VLCFA, lactate |
| Episodic behavioral disturbance with return to baseline | Seizure-related, metabolic disorder with episodic decompensation, migraine variant | Capture episode if possible; EEG; metabolic studies during episode | Prolonged EEG, ammonia during episode, metabolic screen |
| Typical psychiatric presentation, appropriate age, family history | Primary psychiatric disorder (depression, anxiety, bipolar, schizophrenia onset) | Psychiatric evaluation; consider baseline organic workup | Consider: thyroid, metabolic panel, drug screen; MRI if atypical features |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Steps |
|---|---|---|
| Antibody results are pending but clinical suspicion for autoimmune encephalitis is high | Do not wait — consider empiric immunotherapy (steroids, IVIG) after discussion with neurology | Continue workup; early treatment improves outcomes; can be titrated based on response and results |
| MRI and initial CSF are normal but still concerned about autoimmune encephalitis | Normal MRI does not exclude autoimmune encephalitis (30-50% may have normal MRI) | Ensure CSF antibody panel sent to specialized lab; consider repeat LP; treat empirically if high suspicion |
| HSV PCR is negative but still concerned about HSV encephalitis | Continue acyclovir — HSV PCR can be negative in first 24-72 hours | Repeat LP in 3-5 days if suspicion persists; complete 14-21 day course if diagnosis confirmed |
| Parents refuse lumbar puncture | Explain risks and benefits thoroughly; document discussion | May need to proceed with empiric treatment; consider ethics consultation if life-threatening condition suspected |
| Child is too agitated for MRI without sedation | Arrange sedated MRI if clinically indicated; CT as interim if urgent | Do not delay necessary imaging; balance sedation risks against diagnostic need |
| Psychiatric team wants to admit; neurology workup incomplete | Ensure organic workup is complete or ongoing before psychiatric admission | Collaborative care; organic workup can continue on psychiatric unit if necessary but should not be abandoned |
| Child with known psychiatric disorder has acute worsening | Do not assume it’s their psychiatric condition — reassess for organic causes | New symptoms warrant new workup; autoimmune encephalitis can occur in patients with psychiatric history |
| Adolescent denies substance use but clinical picture suggests intoxication | Obtain urine drug screen regardless; approach non-judgmentally | Confidential interview without parents; comprehensive toxicology; maintain therapeutic relationship |
| PANS/PANDAS suspected but strep titers are negative | Negative titers do not exclude PANS (PANDAS requires strep association; PANS does not) | Consider other infectious triggers; autoimmune encephalitis panel; clinical diagnosis may be appropriate |
| Family is pushing for specific diagnosis (e.g., PANDAS) despite unclear evidence | Acknowledge concerns; explain diagnostic criteria objectively | Complete appropriate workup; avoid premature diagnostic labels; consider second opinion if disagreement persists |
When to Involve Specialists
Pediatric Neurology
- Any suspected autoimmune encephalitis
- New-onset seizures with behavioral change
- Movement disorders
- Focal neurological signs
- Developmental regression
- Suspected neurodegenerative disease
- Abnormal neuroimaging
- EEG interpretation and management
Child Psychiatry
- Psychosis (after organic workup initiated)
- Severe mood disturbance
- Suicidal ideation or self-harm
- Diagnostic uncertainty between organic and psychiatric
- Management of psychiatric symptoms in autoimmune conditions
- Long-term psychiatric follow-up
Pediatric Infectious Disease
- Suspected infectious encephalitis
- Unusual or travel-related infections
- Immunocompromised patients
- Antibiotic selection for PANDAS
Pediatric Rheumatology/Immunology
- Autoimmune encephalitis management
- IVIG and immunotherapy guidance
- Systemic autoimmune disease with CNS involvement
- CNS vasculitis
Troubleshooting: Poor Response to Treatment
If the Patient Is Not Improving, Ask:
- Is the diagnosis correct?
- Reconsider organic causes if psychiatric treatment is failing
- Repeat or expand workup — antibodies may have been negative initially
- Consider diagnoses not initially considered
- Is treatment adequate?
- For autoimmune encephalitis: may need escalation (steroids → IVIG → rituximab/cyclophosphamide)
- For PANDAS: may need prolonged antibiotics, IVIG, or immunomodulation
- For psychiatric conditions: adequate dose and duration?
- Is there an underlying tumor?
- Anti-NMDA receptor encephalitis: re-image for ovarian teratoma
- Other paraneoplastic: comprehensive tumor screening
- Are there complicating factors?
- Ongoing seizures (may need EEG monitoring)
- Medication side effects
- Secondary complications (infection, nutritional)
- Psychosocial factors
- Is there a second diagnosis?
- Autoimmune encephalitis can occur in patients with underlying psychiatric disorders
- Multiple etiologies may coexist
Disposition Decision Framework
| Criteria | Admit to PICU | Admit to Ward | Outpatient Management |
|---|---|---|---|
| Consciousness | Significantly altered; GCS ≤12 | Mildly altered or fluctuating | Normal |
| Vital signs | Unstable; autonomic instability | Abnormal but stable | Normal |
| Seizures | Status or recurrent; refractory | Controlled but recent; needs monitoring | None or well-controlled chronic epilepsy |
| Safety risk | Severe agitation requiring sedation | Moderate; needs supervision | Low; safe at home with family |
| Airway/breathing | At risk; may need intubation | Stable | Normal |
| Feeding/hydration | Cannot protect airway; severe refusal | Impaired; may need NG/IV | Adequate oral intake |
| Investigation needs | Requires continuous monitoring during workup | Needs expedited inpatient workup | Can complete workup as outpatient |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Autoimmune encephalitis is a great mimicker: Anti-NMDA receptor encephalitis frequently presents with psychiatric symptoms (psychosis, personality change, catatonia) before neurological signs appear. Psychiatric teams should have a low threshold for autoimmune workup in atypical or treatment-resistant cases.
Orofacial dyskinesias are a red flag: Repetitive movements of the face, tongue, and jaw (lip-smacking, grimacing, chewing movements) in a child with behavioral change are highly suggestive of anti-NMDA receptor encephalitis. This finding should prompt immediate autoimmune workup.
“Overnight” onset of OCD = think PANS: True sudden-onset obsessive-compulsive disorder (developing over 24-48 hours) in a previously well child is not typical of primary OCD. This pattern, especially with tics, anxiety, and emotional lability, should prompt evaluation for PANS/PANDAS.
Visual hallucinations favor organic cause: While auditory hallucinations are common in primary psychotic disorders, visual hallucinations are more suggestive of organic etiology (encephalitis, intoxication, metabolic, or structural brain disease). Always investigate visual hallucinations thoroughly.
Normal MRI does not exclude autoimmune encephalitis: Up to 30-50% of patients with autoimmune encephalitis may have normal brain MRI. CSF analysis with antibody panel is essential; do not be reassured by normal imaging alone.
CSF antibodies are more sensitive than serum: For anti-NMDA receptor antibodies, CSF testing is more sensitive than serum. Up to 14% of patients may be serum-negative but CSF-positive. Always send CSF antibody panel when autoimmune encephalitis is suspected.
Screen for ovarian teratoma in females with anti-NMDA receptor encephalitis: Ovarian teratomas are found in approximately 50% of females over age 12 with anti-NMDA receptor encephalitis. Tumor removal is often necessary for full recovery. Pelvic ultrasound is mandatory.
Wilson disease is treatable — don’t miss it: Wilson disease is one of the few treatable causes of progressive neurodegeneration. Screen for Wilson disease in ANY adolescent with unexplained neuropsychiatric symptoms. Ceruloplasmin and slit lamp examination for Kayser-Fleischer rings are simple initial tests.
Start acyclovir early, think later: Herpes simplex encephalitis is rapidly fatal if untreated but has excellent outcomes with early treatment. If there is any suspicion (fever + behavioral change + altered consciousness), start IV acyclovir immediately — do not wait for HSV PCR results.
Early immunotherapy improves outcomes: In autoimmune encephalitis, early treatment with immunotherapy (corticosteroids, IVIG, or plasma exchange) is associated with better outcomes. If clinical suspicion is high, consider empiric treatment while awaiting antibody results.
Critical Pitfalls to Avoid
Assuming new-onset psychosis in a teenager is primary psychiatric: While schizophrenia can present in adolescence, autoimmune encephalitis is an important differential that requires different treatment. Always complete organic workup before concluding primary psychiatric diagnosis in new-onset psychosis.
Stopping HSV workup when initial PCR is negative: HSV PCR can be negative in the first 24-72 hours of herpes simplex encephalitis. If clinical suspicion persists, continue acyclovir and repeat lumbar puncture in 3-5 days.
Being reassured by normal examination: Many serious conditions causing behavioral change (autoimmune encephalitis, early tumors, metabolic disorders) may have entirely normal neurological examination, especially early in the course. Normal examination does not exclude organic disease.
Forgetting Wilson disease in adolescents: Wilson disease is often missed because psychiatric symptoms may precede neurological findings by months to years. This is a tragedy because Wilson disease is treatable if diagnosed early, but causes progressive, irreversible brain damage if missed.
Attributing new symptoms to known psychiatric diagnosis: Children with psychiatric histories can still develop organic brain disease. New or different symptoms, acute worsening, or treatment resistance should prompt reassessment and consideration of organic causes.
Only ordering serum antibodies in suspected autoimmune encephalitis: Serum testing alone is insufficient. CSF antibody testing is more sensitive for many autoimmune encephalitides and should always be obtained when the diagnosis is suspected.
Delaying treatment while awaiting antibody results: Autoimmune encephalitis antibody results can take 1-2 weeks. If clinical suspicion is high, waiting for results before treating may result in worse outcomes. Empiric immunotherapy should be considered in strong clinical cases.
Dismissing parental concern that “something is different”: Parents know their children best. A parent’s insistence that their child is “not themselves” should be taken seriously, even if the examination is normal. This observation often proves correct.
Missing drug-induced behavioral change: Always take a thorough medication history. Corticosteroids, antiepileptic drugs, montelukast, and many other commonly prescribed medications can cause significant behavioral side effects. Temporal relationship to medication change is key.
Not considering substance use in adolescents: Adolescents may not disclose substance use. Urine drug screen should be part of the workup in any adolescent with acute behavioral change, even if they deny use. Synthetic drugs may not appear on standard screens.
Key Takeaways
- Acute behavioral change is a medical emergency until organic causes are excluded. Infectious and metabolic causes require immediate investigation and treatment.
- Autoimmune encephalitis commonly presents with psychiatric symptoms first. Anti-NMDA receptor encephalitis is the most common autoimmune encephalitis in children and adolescents, and psychiatric manifestations precede neurological signs in the majority of cases.
- PANS/PANDAS presents with dramatic, sudden onset of OCD, tics, and anxiety — this pattern is not typical of primary psychiatric OCD and should prompt evaluation for post-infectious autoimmune etiology.
- Visual hallucinations, altered consciousness, and movement disorders are red flags for organic etiology and warrant thorough neurological investigation.
- Normal MRI and normal neurological examination do not exclude autoimmune encephalitis. CSF analysis with antibody panel is essential; empiric treatment may be appropriate in high-suspicion cases.
- Wilson disease must be excluded in every adolescent with unexplained neuropsychiatric symptoms — it is treatable, but only if diagnosed.
- Early treatment of autoimmune encephalitis improves outcomes. Don’t wait for antibody results if clinical suspicion is high.
- Always consider substances and medications in the differential diagnosis of acute behavioral change, particularly in adolescents.
- Poor response to psychiatric treatment should prompt reconsideration of organic causes and repeat investigation if necessary.
- Multidisciplinary collaboration between neurology, psychiatry, and other specialties is often essential for optimal diagnosis and management.
Quick Reference Algorithm
Systematic Approach to Behavior or Personality Change in Children:
- Assess urgency: Altered consciousness, fever, seizures, autonomic instability, or severe safety risk? → Emergency pathway with immediate workup and empiric treatment
- Establish timeline: Acute (days), subacute (weeks), or chronic (months)? Timeline guides differential and urgency of investigation
- Identify red flags: Visual hallucinations, movement disorders, fluctuating consciousness, regression, focal signs, autonomic instability, atypical age/presentation → Higher suspicion for organic cause
- Complete baseline investigations: CBC, metabolic panel, thyroid, inflammatory markers, ammonia, urinalysis, drug screen in all significant presentations
- Pursue targeted workup based on clinical pattern:
- Subacute + psychiatric + movement disorder → Autoimmune encephalitis panel (CSF essential)
- Overnight OCD/tics → Strep titers, PANS evaluation
- Fever + altered consciousness → LP, HSV PCR, empiric acyclovir
- Progressive + adolescent → Wilson disease screen
- Neuroimaging: MRI brain with contrast for most presentations with red flags; CT if urgent or MRI unavailable
- EEG: If seizures suspected, episodic symptoms, or altered consciousness of unclear etiology
- Do not finalize psychiatric diagnosis until organic causes are excluded: Normal examination and normal MRI are not sufficient; CSF analysis often required
- Consider empiric treatment if high clinical suspicion: Acyclovir for HSV; immunotherapy for autoimmune encephalitis; antibiotics for PANDAS
- Reassess if treatment fails: Poor response to psychiatric treatment should prompt reconsideration and repeat organic workup